Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy). (Q35995472)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy). |
scientific article |
Statements
1 reference
Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy). (English)
1 reference
Jeffery W Kelly
1 reference
Younhee Cho
1 reference
Aleksandra Baranczak
1 reference
Stephen Helmke
1 reference
Sergio Teruya
1 reference
Evelyn M Horn
1 reference
Mathew S Maurer
1 reference
21 July 2015
1 reference
1 reference
175-180
1 reference
2 references
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference